Industry News (Therapy)

Data Presented at American Pain Society Meeting

Published in Cancer Weekly, December 4th, 1995

At the American Pain Society Meeting in Los Angeles, California, Dr. William Brose, Director of the Pain Clinic at Stanford University, Stanford, California, presented his clinical experience with SNX-111 in the treatment of severe pain.

The results in seven patients form part of the Phase I/II study with SNX-111 which was sponsored by Neurex Corporation, Menlo Park, California, and was conducted at several centers in the U.S.

"Based on what I have seen in the patients I have treated, SNX-111 has the potential to provide symptomatic relief in patients who have failed all other pain therapy, without the typical side effects seen with opiates," Brose...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-12-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry